V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10461192 | 10034966 | 1.77 | 58.55 | Curative (C) | 2021-01-12 | 2021-01-14 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101140630 |
| 10461199 | 10034967 | 1.57 | 85.7 | Adjuvant (A) | 2019-02-10 | 2019-03-04 | Capecitabine 35days + RT | 02 | N | CAPECITABINE | 100333319 |
| 10461230 | 10034968 | 1.68 | 66 | null | 2017-04-20 | 2017-04-20 | Rituximab | 02 | null | RITUXIMAB | 100308041 |
| 10461245 | 10034969 | 1.67 | 76.2 | null | 2020-12-13 | 2020-12-20 | CAPECITABINE + OXALIPLATIN | 02 | null | IBRUTINIB | 100559954 |
| 10461260 | 10034970 | null | 56.6 | 03 | 2017-12-29 | 2018-01-19 | Rituximab | N | N | RITUXIMAB | 101400155 |
| 10461273 | 10034971 | 1.7 | 61.5 | Palliative (P) | 2020-04-02 | 2020-04-02 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100020108 |
| 10461289 | 10034972 | 1.71 | 86.6 | Adjuvant (A) | 2021-05-26 | 2021-05-26 | IBRUTINIB | 02 | N | IBRUTINIB | 101270757 |
| 10461304 | 10034973 | 1.73 | 76 | Palliative (P) | 2018-04-20 | 2018-04-20 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100632010 |
| 10461325 | 10034974 | 0 | 73.8 | Curative (C) | 2019-02-25 | 2019-03-14 | IBRUTINIB | 02 | Y | IBRUTINIB | 101795593 |
| 10461330 | 10034975 | 1.71 | 73.2 | null | 2022-05-10 | 2022-05-26 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101065243 |
| 10461334 | 10034976 | 1.66 | 68.8 | Palliative (P) | 2020-12-15 | 2021-01-02 | Rituximab | 02 | N | RITUXIMAB | 100542544 |
| 10461360 | 10034977 | 1.73 | 71 | Palliative (P) | 2019-12-09 | 2019-12-09 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100143402 |
| 10461363 | 10034978 | 1.94 | 64 | null | 2022-03-02 | 2022-03-03 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101417820 |
| 10461366 | 10034979 | 0 | 81 | Palliative (P) | 2015-08-28 | 2017-01-05 | IBRUTINIB | 02 | N | IBRUTINIB | 100432208 |
| 10461386 | 10034980 | 1.69 | 75.2 | Curative (C) | 2017-03-23 | 2017-03-31 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101674447 |
| 10461423 | 10034981 | null | 119 | Curative (C) | 2017-12-21 | 2018-01-09 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101249802 |
| 10461425 | 10034982 | 1.8 | 101.2 | Palliative (P) | 2018-08-02 | 2018-08-07 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101264778 |
| 10461428 | 10034983 | 1.73 | 0 | null | 2021-10-09 | 2021-10-09 | IBRUTINIB | 02 | null | IBRUTINIB | 100382341 |
| 10461431 | 10034984 | 1.7 | 80 | Palliative (P) | null | 2017-09-22 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100918459 |
| 10461433 | 10034985 | 1.77 | null | null | 2018-06-15 | 2018-06-29 | Rituximab | 02 | null | RITUXIMAB | 100764811 |
| 10461437 | 10034986 | 1.82 | 80.3 | Palliative (P) | 2019-04-03 | 2019-04-14 | Capecitabine | 02 | N | CAPECITABINE | 101168462 |
| 10461440 | 10034987 | 1.58 | null | null | 2021-08-17 | 2021-08-26 | IBRUTINIB | 02 | null | IBRUTINIB | 100089662 |
| 10461461 | 10034988 | 1.73 | 64 | Curative (C) | 2018-05-03 | 2018-05-04 | Capecitabine + Oxaliplatin 21day | 02 | N | PEMBROLIZUMAB | 100921497 |
| 10461472 | 10034989 | 1.57 | 71.2 | null | 2016-03-15 | 2016-03-17 | IBRUTINIB | 02 | null | IBRUTINIB | 101664704 |
| 10461494 | 10034990 | 1.64 | 60 | Palliative (P) | 2021-11-07 | 2021-11-09 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100723894 |
| 10461500 | 10034991 | 1.57 | 70 | null | 2021-11-10 | 2021-11-28 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101306533 |
| 10461505 | 10034992 | 1.67 | 89.2 | Palliative (P) | 2016-11-01 | 2016-11-01 | Rituximab | 2 | N | RITUXIMAB | 100874763 |
| 10461514 | 10034993 | 1.63 | 76.2 | Curative (C) | 2020-07-21 | 2020-08-11 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100492047 |
| 10461525 | 10034994 | 1.57 | 64.8 | Palliative (P) | 2018-01-08 | 2018-01-19 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100683068 |
| 10461529 | 10034995 | 1.69 | 88 | 03 | 2016-07-02 | 2016-07-04 | IBRUTINIB | 02 | N | IBRUTINIB | 101668179 |
| 10461578 | 10034996 | null | 73 | Palliative (P) | 2018-03-23 | 2018-03-24 | Rituximab (Maintenance) | 02 | N | RITUXIMAB | 100411331 |
| 10461609 | 10034997 | 1.65 | 74.3 | null | 2020-08-31 | 2020-09-23 | Docetaxel | 02 | null | DOCETAXEL | 100063082 |
| 10461643 | 10034998 | 1.6 | 74.4 | Palliative (P) | null | 2019-03-13 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101389037 |
| 10461644 | 10034999 | 1.62 | 92 | 03 | 2017-11-05 | 2017-11-13 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101202287 |
| 10461665 | 10035000 | 1.78 | 60.5 | Palliative (P) | 2015-12-30 | 2016-01-07 | Rituximab | 02 | N | RITUXIMAB | 101443753 |
| 10461703 | 10035001 | 1.71 | 91.7 | null | 2021-05-27 | 2021-05-31 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100345423 |
| 10461716 | 10035002 | 1.6 | 79 | Palliative (P) | 2017-06-17 | 2017-07-27 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 100707988 |
| 10461736 | 10035003 | 1.81 | 101 | Palliative (P) | 2021-06-20 | 2021-06-21 | CAPECITABINE + OXALIPLATIN | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100188818 |
| 10461750 | 10035004 | 1.67 | 88.4 | null | 2021-05-23 | 2021-05-28 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 101076087 |
| 10461776 | 10035005 | 0 | 54.6 | Curative (C) | 2016-12-08 | 2016-12-19 | CAPECITABINE + OXALIPLATIN | 02 | N | IBRUTINIB | 101864276 |
| 10461788 | 10035006 | 1.74 | 83.9 | null | 2022-02-11 | 2022-02-23 | CAPECITABINE + OXALIPLATIN | 02 | null | PEMBROLIZUMAB | 100061883 |
| 10461833 | 10035007 | 1.55 | 66.8 | 03 | 2015-09-25 | 2015-09-25 | IBRUTINIB | 02 | N | IBRUTINIB | 100514214 |
| 10461852 | 10035008 | 1.54 | 66.3 | Palliative (P) | 2019-02-19 | 2019-02-25 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100872592 |
| 10461859 | 10035009 | 1.73 | 78.7 | Palliative (P) | 2016-11-24 | 2016-11-29 | Rituximab | 02 | N | RITUXIMAB | 100300708 |
| 10461871 | 10035010 | 1.62 | 106 | Adjuvant (A) | 2020-11-16 | 2020-11-24 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100520706 |
| 10461872 | 10035011 | 1.76 | 103.9 | null | 2019-03-08 | 2019-03-08 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101523499 |
| 10461885 | 10035012 | 1.91 | 77.7 | Disease modification (D) | 2017-09-22 | 2017-09-22 | IBRUTINIB | Y | N | IBRUTINIB | 100560887 |
| 10461909 | 10035013 | 1.62 | 45.5 | Palliative (P) | 2016-02-27 | 2016-03-19 | CAPECITABINE + OXALIPLATIN | 02 | N | RITUXIMAB | 101853047 |
| 10461918 | 10035014 | 1.69 | 130 | 03 | 2017-03-08 | 2017-03-26 | Capecitabine + Oxaliplatin 21day | 2 | N | DOCETAXEL | 100568508 |
| 10461922 | 10035015 | 1.73 | 70.5 | Disease modification (D) | 2017-06-16 | 2017-06-16 | IBRUTINIB | 02 | N | IBRUTINIB | 100257590 |